111 related articles for article (PubMed ID: 29336640)
1. Novel RNASET2 Pathogenic Variants in an East Asian Child with Delayed Psychomotor Development.
Sun Y; Hu X; Song J; Hu Y; Liu C; Li G
Fetal Pediatr Pathol; 2018 Feb; 37(1):15-21. PubMed ID: 29336640
[TBL] [Abstract][Full Text] [Related]
2. RNASET2-deficient leukoencephalopathy mimicking congenital CMV infection and Aicardi-Goutieres syndrome: a case report with a novel pathogenic variant.
Kameli R; Amanat M; Rezaei Z; Hosseionpour S; Nikbakht S; Alizadeh H; Ashrafi MR; Omrani A; Garshasbi M; Tavasoli AR
Orphanet J Rare Dis; 2019 Jul; 14(1):184. PubMed ID: 31349848
[TBL] [Abstract][Full Text] [Related]
3. Clinical, radiological and possible pathological overlap of cystic leukoencephalopathy without megalencephaly and Aicardi-Goutières syndrome.
Tonduti D; Orcesi S; Jenkinson EM; Dorboz I; Renaldo F; Panteghini C; Rice GI; Henneke M; Livingston JH; Elmaleh M; Burglen L; Willemsen MA; Chiapparini L; Garavaglia B; Rodriguez D; Boespflug-Tanguy O; Moroni I; Crow YJ
Eur J Paediatr Neurol; 2016 Jul; 20(4):604-10. PubMed ID: 27091087
[TBL] [Abstract][Full Text] [Related]
4. RMND1-Related Leukoencephalopathy With Temporal Lobe Cysts and Hearing Loss-Another Mendelian Mimicker of Congenital Cytomegalovirus Infection.
Ulrick N; Goldstein A; Simons C; Taft RJ; Helman G; Pizzino A; Bloom M; Vogt J; Pysden K; Diodato D; Martinelli D; Monavari A; Buhas D; van Karnebeek CD; Dorboz I; Boespflug-Tanguy O; Rodriguez D; Tétreault M; Majewski J; Bernard G; Ng YS; ; McFarland R; Vanderver A
Pediatr Neurol; 2017 Jan; 66():59-62. PubMed ID: 27843092
[TBL] [Abstract][Full Text] [Related]
5. RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection.
Henneke M; Diekmann S; Ohlenbusch A; Kaiser J; Engelbrecht V; Kohlschütter A; Krätzner R; Madruga-Garrido M; Mayer M; Opitz L; Rodriguez D; Rüschendorf F; Schumacher J; Thiele H; Thoms S; Steinfeld R; Nürnberg P; Gärtner J
Nat Genet; 2009 Jul; 41(7):773-5. PubMed ID: 19525954
[TBL] [Abstract][Full Text] [Related]
6. Zebrafish disease model of human RNASET2-deficient cystic leukoencephalopathy displays abnormalities in early microglia.
Weber T; Schlotawa L; Dosch R; Hamilton N; Kaiser J; Schiller S; Wenske B; Gärtner J; Henneke M
Biol Open; 2020 May; 9(5):. PubMed ID: 32295832
[TBL] [Abstract][Full Text] [Related]
7. RNASET2 tag SNP but not CCR6 polymorphisms is associated with autoimmune thyroid diseases in the Chinese Han population.
Chen XJ; Gong XH; Yan N; Meng S; Qin Q; Jiang YF; Zheng HY; Zhang JA
BMC Med Genet; 2015 Feb; 16():11. PubMed ID: 25928629
[TBL] [Abstract][Full Text] [Related]
8. Tumor and metastasis suppression by the human RNASET2 gene.
Acquati F; Possati L; Ferrante L; Campomenosi P; Talevi S; Bardelli S; Margiotta C; Russo A; Bortoletto E; Rocchetti R; Calza R; Cinquetti R; Monti L; Salis S; Barbanti-Brodano G; Taramelli R
Int J Oncol; 2005 May; 26(5):1159-68. PubMed ID: 15809705
[TBL] [Abstract][Full Text] [Related]
9. rnaset2 mutant zebrafish model familial cystic leukoencephalopathy and reveal a role for RNase T2 in degrading ribosomal RNA.
Haud N; Kara F; Diekmann S; Henneke M; Willer JR; Hillwig MS; Gregg RG; Macintosh GC; Gärtner J; Alia A; Hurlstone AF
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1099-103. PubMed ID: 21199949
[TBL] [Abstract][Full Text] [Related]
10. Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
Gonsky R; Fleshner P; Deem RL; Biener-Ramanujan E; Li D; Potdar AA; Bilsborough J; Yang S; McGovern DPB; Targan SR
Gastroenterology; 2017 Jul; 153(1):219-232. PubMed ID: 28400196
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 6 encoded RNaseT2 protein is a cell growth regulator.
Liu J; Zhawar VK; Kaur G; Kaur GP; Deriel JK; Kandpal RP; Athwal RS
J Cell Mol Med; 2010 May; 14(5):1146-55. PubMed ID: 19382914
[TBL] [Abstract][Full Text] [Related]
12. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
13. [Association of RNASET2 gene polymorphisms and haplotypes with Graves disease in Han Chinese population from coastal regions of Shandong].
Wang BP; Han L; Tong JJ; Wang Y; Jia ZT; Sun MX; Wang HL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):693-6. PubMed ID: 24327149
[TBL] [Abstract][Full Text] [Related]
14. A recombinant human RNASET2 glycoprotein with antitumorigenic and antiangiogenic characteristics: expression, purification, and characterization.
Smirnoff P; Roiz L; Angelkovitch B; Schwartz B; Shoseyov O
Cancer; 2006 Dec; 107(12):2760-9. PubMed ID: 17109444
[TBL] [Abstract][Full Text] [Related]
15.
Sinkevicius KW; Morrison TR; Kulkarni P; Caffrey Cagliostro MK; Iriah S; Malmberg S; Sabrick J; Honeycutt JA; Askew KL; Trivedi M; Ferris CF
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29752287
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients.
Al Mutairi F; Alfadhel M; Nashabat M; El-Hattab AW; Ben-Omran T; Hertecant J; Eyaid W; Ali R; Alasmari A; Kara M; Al-Twaijri W; Filimban R; Alshenqiti A; Al-Owain M; Faqeih E; Alkuraya FS
Pediatr Neurol; 2018 Jan; 78():35-40. PubMed ID: 29239743
[TBL] [Abstract][Full Text] [Related]
17. A potential role of human RNASET2 overexpression in the pathogenesis of Graves' disease.
Gallo D; De Vito A; Roncoroni R; Bruno A; Piantanida E; Bartalena L; Tanda ML; Mortara L; Acquati F
Endocrine; 2023 Jan; 79(1):55-59. PubMed ID: 36180758
[TBL] [Abstract][Full Text] [Related]
18. Stress-induced RNASET2 overexpression mediates melanocyte apoptosis via the TRAF2 pathway in vitro.
Wang Q; Jiang M; Wu J; Ma Y; Li T; Chen Q; Zhang X; Xiang L
Cell Death Dis; 2014 Jan; 5(1):e1022. PubMed ID: 24457966
[TBL] [Abstract][Full Text] [Related]
19. New insights into hypoxia-related mechanisms involved in different microvascular patterns of bronchopulmonary carcinoids and poorly differentiated neuroendocrine carcinomas. Role of ribonuclease T2 (RNASET2) and HIF-1α.
Uccella S; La Rosa S; Scaldaferri D; Monti L; Maragliano R; Sorrenti E; Gariboldi M; Taramelli R; Sessa F; Acquati F
Hum Pathol; 2018 Sep; 79():66-76. PubMed ID: 29763721
[TBL] [Abstract][Full Text] [Related]
20. Whole exome sequencing identifies a novel 5 Mb deletion at 14q12 region in a patient with global developmental delay, microcephaly and seizures.
Vineeth VS; Dutta UR; Tallapaka K; Das Bhowmik A; Dalal A
Gene; 2018 Oct; 673():56-60. PubMed ID: 29920362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
